cartouche ECN WORKSHOP
-

Abstracts

Oral communications

Posters

1

2017 - Poster

Mechanisms-Epidemiology

Serum uric acid level variations during gout attacks are linked neither to inflammation nor to uric acid fractional excretion: a prospective study of 35 patients

Vanina Masson Behar (1), Carole Desthieux (1), Caroline Aparicio (2), Philippe Manivet (3), Thomas Bardin (1), Pascal Richette (1), Frédéric Lioté (1), Agnès Ostertag (1), Hang-Korng Ea (1)

2

2017 - Poster

Mechanisms-Epidemiology

Ready or not ? Changes in the clinical profile of gout patients over the last 25 years

Sandra P. Chinchilla (1,2), Irati Urionagüena (1,3), Fernando Perez-Ruiz (1,2,3)

3

2017 - Poster

OA-Genetics and EUROGOUT-Inflammation

Gout at the spine : a retrospective study with dual-energy computed tomography

E. Chotard (1), J. M. Sverzut (2) , F. Lioté (1,3), T. Bardin (1,3), H.K. Ea (1,3)

5

2017 - Poster

Mechanisms-Epidemiology

Self-reported triggers of acute gout and age of gout onset: a primary care based cross-sectional study

Abhishek Abhishek, Ana M. Valdes, Wendy Jenkins, Weiya Zhang, Michael Doherty

7

2017 - Poster

OA-Genetics and EUROGOUT-Inflammation

Circulating cytokines and homeostatic molecules are correlated to serum uric acid levels in gout and metabolic syndrome patients

Tania O. Crișan (1,2), Maartje C.P. Cleophas (1), Rob ter Horst (1), Inge van de Munckhof (1), Joost Rutten (1), Tim L. Jansen (3), Niels Riksen (1), Charles Dinarello (1,4), Mihai G. Netea (1), Leo A.B. Joosten (1,2)

8

2017 - Poster

Therapeutics-Miscellaneous

Hydrogen sulfide inhibits NLRP3 inflammasome activation induced by monosodium urate crystals

Mariela Castelblanco (1), Jerome Lugrin (2), Driss Ehirchiou (2), Isao Ishii (3), Sonia Nasi (1), Alexander So (1), Fabio Martinon (2), Nathalie Busso (1)

10

2017 - Poster

Therapeutics-Miscellaneous

Effect of dialysis and low dose urate-lowering on serum urate levels in patients with gout

I. Urionagüena (1,2), SP. Chinchilla (2,3), G. Garcia Erauzkin (4), ML. Muñiz-Gomez (4), F. Pérez-Ruiz (1,2,3)

11

2017 - Poster

OA-Genetics and EUROGOUT-Inflammation

Calcium pyrophosphate and monosodium urate crystal-induced prostaglandin E2 production involves NF-κB activation and ROS production, independently of interleukin-1beta axis

Félix Renaudin (1), Laure Campillo-Gimenez (1), Christèle Combes (2), Marjolaine Gosset (3), Martine Cohen-Solal (1,4), Frédéric Lioté (1,4), Hang-Korng Ea (1,4)

12

2017 - Poster

Mechanisms-Epidemiology

On the incidence of gout flares in primary care; a retrospective cohort study

Hein Janssens (1), Matthijs Janssen (2), Jaap Fransen (3), Marcel Flendrie (4)

13

2017 - Poster

Therapeutics-Miscellaneous

Cardiovascular risk and endothelial dysfunction in patients with gout. Experience in a spanish multi-hospital group

E. Calvo Aranda, O. Carrion, A. Abdelkader, JJ. Gonzalez-Martin, F. Aramburu, C. Marin, S. Rodriguez Rubio, M . Valero, F. Sainz, P. Garcia de la Peña Lefebvre

14

2017 - Poster

Mechanisms-Epidemiology

Ultrasonography and dual-energy CT (DECT) do not provide the same quantification of urate deposition in gout : results from a cross-sectional study

Tristan Pascart, Agathe Grandjean, Laurène Norberciak, Vincent Ducoulombier, Marguerite Motte, Hélène Luraschi, Marie Vandecandelaere, Catherine Godart, Eric Houvenagel, Nasser Namane, Jean-François Budzik